Subramanian Romesh 4
4 · Dyne Therapeutics, Inc. · Filed Sep 18, 2020
Insider Transaction Report
Form 4
Subramanian Romesh
Chief Scientific Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
2020-09-16+128,185→ 128,185 totalExercise: $19.00Exp: 2030-09-15→ Common Stock (128,185 underlying) - Award
Common Stock
2020-09-17+41,309→ 566,249 total
Footnotes (2)
- [F1]Consists of shares of Common Stock issuable under 41,309 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on September 17, 2021.
- [F2]This option was granted on September 16, 2020. The shares underlying the option are scheduled to vest over four years in equal monthly installments through September 16, 2024.